Paul B Fisher

Scarsdale, NY, United States of America

Paul B Fisher

This inventor holds 57 USPTO granted patents and 17 published patent applications, plus 1 CIPO patent and 7 EPO patents, primarily in Cancer Therapeutics (CPC class C12N). Top assignees: Columbia University, Virginia Commonwealth University, Johns Hopkins University. Active years: 1997-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul B Fisher. Retrieved from https://idiyas.com/inventor/paul-b-fisher

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 57 

% Patents Active = 77.2

 

 

Average Co-Inventor Count = 1.6

ph-index = 7

Forward Citations = 222(Granted Patents)

Forward Citations (Not Self Cited) = 179(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Ellis, KS (US) (2002)
  • Dexter, MI (US) (2003)
  • Scardale, NY (US) (2005)
  • Scarsdale, NY (US) (1997 - 2009)
  • West Palm Beach, FL (US) (2014 - 2016)
  • Richmond, VA (US) (2016 - 2020)
  • Henrico, VA (US) (2021 - 2024)

Company Filing History:


Years Active: 1997-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Cancer Invasion Inhibitors
Theranostic Constructs
MDA-7 Proteins
Chimeric Genes
Melanoma Differentiation
Prostate Tumor Inducing Gene
Cytokine Therapeutics
Nucleic Acid Probes
Cancer Cell Death
Tumor Suppressor Genes
Genetic Expression Regulation
57 patents (USPTO):Explore Patents

Title: The Innovative Mind of Paul B. Fisher

Introduction

Paul B. Fisher, an esteemed inventor based in Scarsdale, NY, has made significant contributions to the field of cancer research with an impressive portfolio of 56 patents. His work focuses on developing novel therapies that target the mechanisms of cancer invasion and metastasis, showcasing his dedication to advancing medical science and improving patient outcomes.

Latest Patents

Among Fisher's latest patents are groundbreaking compositions that inhibit cancer invasion, attachment, and metastasis. These innovations involve compositions that bind to the PDZ1 domain of MDA-9/Syntenin (syndecan binding protein: SDCBP), effectively blocking its activity. The methods outlined in these patents are particularly useful for treating cancers characterized by elevated MDA-9/Syntenin expression, positioning Fisher at the forefront of cancer therapeutics.

Career Highlights

Throughout his career, Paul B. Fisher has been affiliated with reputable institutions such as Columbia University and Virginia Commonwealth University, where he has conducted pivotal research that has led to numerous innovations in cancer treatment. His extensive experience in academia and research underlines the impact of his contributions to the scientific community.

Collaborations

Fisher's work has often been enriched through collaborations with notable peers, including Devanand Sarkar and Swadesh K. Das. These partnerships not only reflect his ability to work within multidisciplinary teams but also amplify the potential for translating research findings into therapeutic solutions that can change lives.

Conclusion

With 56 patents to his name and ongoing research that addresses critical challenges in cancer treatment, Paul B. Fisher is a remarkable inventor whose work continues to inspire and drive innovation in the medical field. His focus on inhibiting cancer metastasis underscores an urgent need for effective therapies and demonstrates his commitment to advancing human health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…